menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

New Advancements in the Prevention of RSV in Infancy and Pregnancy

ReachMD Healthcare Image
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Comments
  • Overview

    Respiratory syncytial virus (RSV) is a common respiratory virus that can cause serious illness in young children, especially premature babies, and those with underlying health conditions. However, the FDA recently approved a drug to prevent RSV in babies and toddlers as well as the first vaccine for pregnant patients. Learn more about how these developments could help address the heavy burden facing our youngest patients and their families.

Facebook Comments

Recommended
Details
Comments
  • Overview

    Respiratory syncytial virus (RSV) is a common respiratory virus that can cause serious illness in young children, especially premature babies, and those with underlying health conditions. However, the FDA recently approved a drug to prevent RSV in babies and toddlers as well as the first vaccine for pregnant patients. Learn more about how these developments could help address the heavy burden facing our youngest patients and their families.

Facebook Comments

Schedule25 May 2024